Catalyst Wire Dossier Catalyst Wire Dossier

Gimsilumab

Gimsilumab · Kinevant Sciences GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gimsilumab, covering 2021-12-10 to 2021-12-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE) [Phase 2]

See pricing